Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives
Hoyli Ooi,Carly Welch
DOI: https://doi.org/10.2147/cia.s438144
IF: 3.829
2024-02-20
Clinical Interventions in Aging
Abstract:Hoyli Ooi, 1 Carly Welch 1, 2 1 Department of Ageing and Health, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, UK; 2 Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, St Thomas' Campus, King's College London, London, UK Correspondence: Carly Welch, Department of Twin Research & Genetic Epidemiology King's College London, St Thomas' Campus 3rd & 4th Floor South Wing Block D Westminster Bridge Road, London, SE1 7EH, UK, Tel +44 (0) 20 7188 6765, Email Research in sarcopenia has grown exponentially over the last 15 years in geriatrics and gerontology, as well as other specialties, including oncology and hepatology. There is now strong evidence for the role of resistance exercise to prevent declines in muscle strength and function, especially when combined with nutritional optimization with protein supplementation. However, there remains a disparity between research evidence and clinical practice. There are multiple factors for this, which relate to the current diagnostic criteria for sarcopenia, practical and logistical aspects of diagnosis of sarcopenia, clinician knowledge of both diagnosis and management, and the availability of pathways for interventions. Sarcopenia is currently defined based on the identification of muscle strength, in combination with muscle size or quality, below cut-off thresholds at a single timepoint. This defines sarcopenia as a binary process of either present or not present, thus early diagnosis can be challenging. In this article, we summarize current obstacles to early diagnosis and management of sarcopenia in clinical practice, and make recommendations to how these might be overcome. This includes our recommendation of incorporation of handgrip strength measurement into standard care, to enable dynamic assessment and identification of early declines in handgrip strength, so that interventions can be implemented to prevent disability. Keywords: EWGSOP2, dynamic change, handgrip strength, implementation, exercise Sarcopenia has gained increasing recognition among researchers and clinicians, as it has been shown to be associated with increased likelihood of adverse outcomes including falls, 1 fractures, 2 physical disability, 3 and mortality. 1 Multiple operational working groups including the European Working Group on Sarcopenia in Older People [EWGSOP (2010)], 4 revised EWGSOP2 (2019), 5 Asian Working Group for Sarcopenia (AWGS), 6 International Working Group on Sarcopenia (IWGS), 7 and Foundation for the National Institute of Health (FNIH), 8 have proposed sarcopenia definitions. The prevalence of sarcopenia ranges between 10% and 27% dependent on definition used. 9 In 2010, The European Working Group on Sarcopenia in Older People (EWGSOP) produced a landmark paper that classifies sarcopenia as a geriatric syndrome characterized by loss of muscle mass and function. 4 Ten years following this, with advances in clinical research, EWGSOP revised its original definition in 2019 (EWGSOP2). EWGSOP2 focuses more on low muscle strength as the main criterion for sarcopenia, and the diagnosis is confirmed by low muscle quality or quantity, with poor physical performance as an indicator for severe sarcopenia. 5 The shift towards focus on muscle strength was driven by evidence demonstrating that grip strength was a greater predictor of adverse outcomes than muscle mass. 10 The Asian Working Group for Sarcopenia (AWGS) 2019 echoed the general EWGSOP2 definition, with its differences mainly on the diagnostic cut-off values reflective of the regional population and having two separate algorithms for community vs hospital settings. 6 Evidence has shown that progressive resistance exercise training can improve muscle strength and muscle mass in older adults. 11 The "Sarcopenia and Physical Frailty in Older People: Multicomponent Treatment Strategies" (SPRINTT) randomized controlled trial (RCT) showed positive effects of physical activity and nutrition intervention to prevent mobility disability and improve physical performance. 12 Despite a myriad of clinical research findings and recommendations in place to manage sarcopenia, it remains challenging to achieve early diagnosis and management of sarcopenia in clinical practice. This article summarizes the multiple obstacles at different stages (Figure 1), and recommendations about how these might be overcome. Figure 1 Challenges to early diagnosis and management, including inter-relation between diagnosis and management. Muscle strength is now considered the primary determinant of sarcopenia. EWGSOP2 recommends using assessment of -Abstract Truncated-
geriatrics & gerontology,gerontology